Department of Urology, Yeungnam University College of Medicine, Daegu, Korea
Copyright © 2023 Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
Funding
This work was supported by a grant from the Chunma Medical Research Foundation, Korea, 2021.
Variable | Data |
---|---|
No. of patients | 107 |
Age (yr) | 66.50±6.29 |
Prostate volume (mL) | 30.26±12.52 |
Preoperative PSA (ng/mL) | 17.46±27.42 |
Duration of catheterization (day) | 8.16±3.11 |
Pathologic state | |
≤T2 | 57 (53.3) |
≥T3 | 50 (46.7) |
NVB sparing | |
Unilateral | 24 (22.4) |
Bilateral | 83 (77.6) |
Bladder neck preservation | 67 (62.6) |
Recovery of incontinence (mo) | |
1 | 47 (43.9) |
3 | 71 (66.4) |
6 | 94 (87.9) |
12 | 104 (97.2) |
Regain of continence (day) | 79.88±86.21 |
Factor | 1 Mo |
3 Mo |
6 Mo |
12 Mo |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Incontinence (n=60) | Continence (n=47) | p-value | Incontinence (n=36) | Continence (n=71) | p-value | Incontinence (n=13) | Continence (n=94) | p-value | Incontinence (n=3) | Continence (n=104) | p-value | |
Age (yr) | 66.23±6.17 | 66.83±6.48 | 0.629 | 65.92±6.14 | 66.79±6.38 | 0.500 | 67.54±5.82 | 66.35±6.36 | 0.526 | 63.33±6.65 | 66.59±6.28 | 0.379 |
Prostate volume (mL) | 32.45±14.56 | 27.46±8.64 | 0.04 | 29.92±12.35 | 30.43±12.68 | 0.843 | 29.57±12.04 | 30.35±12.64 | 0.834 | 42.09±16.89 | 29.91±12.31 | 0.097 |
Preoperative PSA (ng/mL) | 16.05±24.06 | 19.26±31.37 | 0.551 | 20.27±29.64 | 16.04±26.32 | 0.454 | 15.15±16.53 | 17.78±28.65 | 0.748 | 6.05±3.01 | 17.79±27.74 | 0.467 |
Pathologic stage (n) | 0.115 | 0.942 | 0.524 | 0.100 | ||||||||
T2 | 36 | 21 | 19 | 38 | 8 | 49 | 3 | 54 | ||||
T3 | 24 | 26 | 17 | 33 | 5 | 45 | 0 | 50 | ||||
NVB sparing (n) | 0.800 | 0.345 | 0.139 | 0.345 | ||||||||
Unilateral | 14 | 10 | 10 | 14 | 5 | 19 | 0 | 24 | ||||
Bilateral | 46 | 37 | 26 | 57 | 8 | 75 | 3 | 80 | ||||
Bladder neck preservation | 29 | 38 | 0.001 | 19 | 48 | 0.134 | 5 | 62 | 0.055 | 1 | 66 | 0.288 |
Postoperative cystography parameter | ||||||||||||
BNAP ratio | 0.267±0.059 | 0.188±0.022 | <0.001 | 0.299±0.047 | 0.198±0.031 | <0.001 | 0.335±0.032 | 0.217±0.048 | <0.001 | 0.336±0.055 | 0.229±0.058 | 0.002 |
Vesicourethral angle | 98.51±12.14 | 116.29±5.41 | <0.001 | 94.84±11.26 | 112.15±9.85 | <0.001 | 90.13±9.97 | 108.56±11.96 | <0.001 | 82.60±189.01 | 107.01±12.46 | 0.001 |
BNPS ratio | 0.509±0.163 | 0.410±0.155 | 0.002 | 0.526±0.165 | 0.434±0.160 | 0.007 | 0.574±0.186 | 0.450±0.159 | 0.011 | 0.585±0.235 | 0.462±0.164 | 0.210 |
Factor | Postoperative 1 mo (47/107) |
Postoperative 3 mo (71/107) |
Postoperative 6 mo (94/107) |
|||
---|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (yr) | 0.943 (0.838–1.062) | 0.336 | 1.039 (0.888–1.217) | 0.631 | 0.919 (0.718–1.175) | 0.501 |
Prostate volume (mL) | 1.092 (1.020–1.170) | 0.012 | 1.030 (0.950–1.118) | 0.471 | 1.024 (0.920–1.141) | 0.661 |
Preoperative PSA (ng/mL) | 0.997 (0.968–1.027) | 0.851 | 1.036 (1.000–1.074) | 0.051 | 1.029 (0.943–1.123) | 0.524 |
Pathologic stage | 1.248 (0.192–8.096) | 0.817 | 0.142 (0.013–1.499) | 0.105 | 8.945 (0.115–98.425) | 0.524 |
NVB sparing | 1.684 (0.188–15.065) | 0.641 | 0.044 (0.002–1.223) | 0.066 | 3.177 (0.222–45.477) | 0.139 |
No bladder neck preservation | 0.279 (0.057–1.367) | 0.115 | 4.290 (0.369–49.912) | 0.245 | 0.147 (0.014–1.516) | 0.107 |
BNAP ratio | 3.795 (2.829–5.089) | 0.006 | 3.867 (2.181–5.384) | <0.001 | 3.648 (2.694–5.041) | 0.002 |
Vesicourethral angle | 0.800 (0.701–0.913) | 0.001 | 0.885 (0.806–0.971) | 0.010 | 0.866 (0.765–0.980) | 0.023 |
BNPS ratio | 0.098 (0.000–34.073) | 0.436 | 0.013 (0.000–9.100) | 0.193 | 7.155 (0.024–21.325) | 0.295 |
Factor | HR (95% CI) | p-value |
---|---|---|
Age (yr) | 1.029 (0.995–1.063) | 0.092 |
Prostate volume (mL) | 0.993 (0.976–1.010) | 0.412 |
Preoperative PSA (ng/mL) | 1.001 (0.993–1.009) | 0.880 |
Pathologic stage (T3) | 0.786 (0.501–1.232) | 0.293 |
Bilateral NVB sparing | 1.061 (0.527–2.138) | 0.868 |
No bladder neck preservation | 0.608 (0.393–0.938) | 0.025 |
BNAP ratio | 0.416 (0.146–0.987) | <0.001 |
Vesicourethral angle | 1.056 (1.032–1.080) | <0.001 |
BNPS ratio | 0.924 (0.208–4.109) | 0.917 |
Parameter | Sensitivity | Specificity | Youden’s index | Optimal cut-off | AUC | 95% CI | p-value |
---|---|---|---|---|---|---|---|
BNPS ratio | 0.350 | 0.957 | 0.307 | 0.584 | 0.650 | 0.546–0.754 | 0.008 |
Vesicourethral angle | 0.915 | 0.817 | 0.732 | 108.5 | 0.918 | 0.866–0.970 | <0.001 |
BNAP ratio | 0.800 | 0.979 | 0.779 | 0.224 | 0.898 | 0.835–0.961 | <0.001 |
Values are presented as number only, mean±standard deviation, or number (%). PSA, prostate-specific antigen; NVB, neurovascular bundle.
Values are presented as mean±standard deviation or number. PPI, post-prostatectomy incontinence; PSA, prostate-specific antigen; NVB, neurovascular bundle; BNAP, bladder neck anteroposterior length; BNPS, bladder neck to pubic symphysis.
PPI, post-prostatectomy incontinence; OR, odds ratio; CI, confidence interval; PSA, prostate-specific antigen; NVB, neurovascular bundle; BNAP, bladder neck anteroposterior; BNPS, bladder neck to pubic symphysis.
PPI, post-prostatectomy incontinence; HR, hazard ratio; CI, confidence interval; PSA, prostate-specific antigen; NVB, neurovascular bundle; BNAP, bladder neck anteroposterior; BNPS, bladder neck to pubic symphysis.
ROC, receiver operating characteristic; AUC, area under the curve; CI, confidence interval; BNPS, bladder neck to pubic symphysis; BNAP, bladder neck anteroposterior.